MTOR and urinary bladder carcinoma: Examples include afatinib-celastrol against non-small cell lung cancer cells [64], paclitaxel-honokiol against non-small cell lung cancer cells [155], and the mTOR inhibitor jolkinolide B in bladder cancer cells [160].